|
≥2 medication trials
|
Fregni F, et al. (2006) [24]
| |
Higher response rate to rTMS therapy in patients who had a lower number of refractory treatment trials.
|
|
≤1 medication trial
|
Huang M-L, et al. (2012) [26];
|
rTMS plus med vs. sham plus med
|
Significantly higher number of improvers at 4 weeks with rTMS plus med.
|
|
Wang H-N, et al. (2017) [27];
|
rTMS plus med vs. med
|
Significantly higher number in response and remission at 12 months with rTMS plus med.
|
|
Wang Y-M, et al. (2017) [28];
|
rTMS plus med vs. sham plus med
|
Response and remission significantly higher in the rTMS + med
|
|
Yang H, et al. (2017) [29]
|
rTMS plus med vs. sham plus med
|
Response and remission significantly higher in the rTMS + med
|
|
≥2 medication trials vs. ≤1 medication trial
|
Brakemeier E-L, et al. (2007) [30];
|
Use of rTMS with Low (1 trial) vs. high (≥2 trials) medication treatment resistance
|
Likelihood of response was higher in low treatment resistant patients
|
|
O’Reardon JP, et al. (2009) [25];
|
Use of rTMS with Low (1 trial) vs. high (≥2 trials) medication treatment resistance
|
Likelihood of response was 4X higher and statistically significantly different in low treatment resistant patients
|
|
Brakemeier E-L, et al. (2008) [31];
|
Use of rTMS with Low (1 trial) vs. high (≥2 trials) medication treatment resistance
|
Use of rTMS in low treatment resistant patients had a statistically significant effect on improved outcomes
|
|
Cohen RB, et al. (2010) [32];
|
Use of rTMS with Low (1 trial) vs. high (≥2 trials) medication treatment resistance
|
Use of rTMS in low treatment resistant patients had a statistically significant effect on improved outcomes
|
|
Carpenter LL, et al. (2012); [33]
|
Use of rTMS with Low (≤1 trial) vs. high (≥2 trials) medication treatment resistance
|
Use of rTMS in low treatment resistant patients had a modest effect on improving outcomes.
|
